• Blog

The physician practice management (PPM) and practice consolidation market has heated up in 2025, fueled by renewed private equity interest, specialty-focused roll-ups, and the push toward value-based care. As investors pour billions into high-growth healthcare verticals like orthopedics, cardiology, ENT, and pediatrics, physician groups face both exciting opportunities and complex challenges. Whether you’re considering a merger, exploring private equity backing, or navigating heightened regulatory scrutiny, understanding these trends is critical. That’s where The Bloom Organization, a leading healthcare investment firm, steps in: helping practices chart a strategic path through today’s dynamic consolidation landscape.

What’s Hot in Practice Consolidation and PPM Today

1. Renewed Private Equity Surge

Private equity is making a major comeback in PPM. After slower activity in 2024, PE‑backed deals rebounded sharply in Q1 2025 — from 128 to 140 transactions — highlighting renewed investor confidence. With approximately $75 billion in dry powder, investors are targeting specialty verticals that offer predictable revenue and value-based care alignment.

2. Specialty Practices Under Consolidation Spotlight

High-margin specialties continue to dominate orchestration efforts. Since 2017, there have been nearly 4,000 PE‑backed transactions across dermatology, urology, fertility, cardiology, ENT/allergy, orthopedics, oncology, gastroenterology and more. Infusion suites are also drawing interest due to their fragmented structure and synergy potential.

Emerging specialties like pediatrics and behavioral health are now attracting investors aiming for scale and deeper value‑based care models. 

3. Value‑Based Care Is Key

Shifting from fee‑for‑service to value‑based and risk‑based compensation is changing how practices merge and manage performance. Investors are looking for PPM platforms that can win shared‑savings contracts, manage chronic disease and integrate tech to boost outcomes. 

4. Regulatory Pressure Isn’t Slowing Deals

Heightened state/federal scrutiny hasn’t stopped consolidation — but it is reshaping deal structures. Advanced notifications, increased due diligence, and innovative compliance frameworks are now par for the course.

Consolidation & M&A Outlook

• Outpatient & Post‑Acute Services: Hospice, home‐health, infusion and outpatient surgical services are also active consolidation targets, driven by high fragmentation and PE interest 
• PE Exit Cycle Resurgence: With several large roll‑ups and exits closing in late 2024, including ophthalmology and GI platforms topping $2–4 billion, experts anticipate 2025 as the year PE-backed PPMs come back to market The Bloom Organization, LLC
• Operational Efficiency Post-Close: PE firms are doubling down on integration, automation, and centralized revenue cycle management to generate ROI amid a more cautious macro environment.
  

How The Bloom Organization Can Help

1. Deep Sector Expertise

As a 30‑year healthcare investment bank for physician‑owned practices, Bloom has completed over 100 transactions across specialties — from orthopedics to ENT+allergy — closing more than $10 billion in deals The Bloom Organization, LLC+1Business Wire+1.

2. Tailored Strategies for PE and Health‑system Partners

Whether you’re seeking PE backing, merging into a health system, or forming an MSO, Bloom brings deep market relationships and deal structuring capabilities to maximize valuations and regulatory resilience.

3. Regulatory & Integration Advantage

Their experience advising specialty groups through advanced merger notifications and structuring around state regulations provides strategic certainty. They also support post‑acquisition integration via MSO formation and tech‑enabled infrastructure — streamlining front/back office, revenue cycle, and care delivery workflows.

4. M&A Execution & Exit Positioning

Bloom helps physician owners balance autonomy and liquidity — structuring equity rollovers, carve‑outs, and exit-ready platforms that speak both to PE investors and strategic buyers.

Trends You Should Be Watching

Trend	Why It Matters
PE Re‑entry	With over $75B in dry powder, we’re entering a high‑deal environment in 2025.
Specialty Expansion	ENT, cardiology, oncology, infusion, and pediatrics are the new frontiers.
Value-Based Alignment	Investors are targeting performance‑driven, risk‑contractified platforms.
Regulatory Savvy	Deals now require layered compliance and deal structuring expertise.
Tech-Enabled Efficiency	Post-close integration and automation are essential for returns.

Is Your Practice Ready?

The consolidation wave is accelerating — whether via PE support, MSO partnerships, hospital alignment, or joint‑venture structures. The Bloomberg Organization can help with:

• Valuation & readiness assessment
  
• Buyer‑market positioning (PE, strategic, MSO, health systems)
  
• Regulatory-compliant deal design & negotiation
  
• Integration planning for MSO/platform builds
  
• Equity structure for founders & physicians
  

Bottom Line

The Practice Consolidation & PPM space is growing rapidly in 2025:

• Renewed private equity interest backed by abundant capital
  
• Specialty-heavy roll-ups targeting scalable, value-based platforms
  
• Advanced regulatory scrutiny shaping deal mechanics
  
• Integration and tech as key to delivering ROI
  

With The Bloom Organization’s deep domain expertise — $10B+ in deals, 5,000+ physicians served, 100+ transactions closed — they’re uniquely positioned to guide founder/practitioner‑owners and investors through these complex waters.

---

Curious how your specialty fits in? Want a discreet conversation on valuation or partnership options? Coordinate an initial chat with Bloom’s expert advisory team.